83
Participants
Start Date
June 30, 2013
Primary Completion Date
January 31, 2016
Study Completion Date
January 31, 2016
Liposomal Doxorubicin
"Six cycles of:~* Trastuzumab 4 mg/kg loading dose on Day 1 of the first cycle, then 2 mg/kg on Days 8 and 15 of the first cycle and on Days 1, 8, and 15 of the subsequent cycles, every 3 weeks~* Pertuzumab 840 mg loading dose on Day 1 of the first cycle, then 420 mg on Day 1, every 3 weeks~* Liposomal doxorubicin 50 mg/m2 on Day 1, every 3 weeks~* Paclitaxel 80 mg/m2 on Days 1, 8, and 15, every 3 weeks"
Hospital Universitario 12 de Octubre, Madrid
Hospital Clínic de Barcelona, Barcelona
Hospital Universitario Vall d´Hebron, Barcelona
Complejo Hospitalario San Pedro de Alcántara, Cáceres
Hospital Universitari Arnau de Vilanova de Lleida, Lleida
Centro Integral Oncológico Clara Campal, Madrid
Hospital Universitario Clínico San Carlos, Madrid
Hospital Universitario Puerta de Hierro de Majadahonda, Madrid
MD Anderson Cancer Center Madrid, Madrid
Hospital Universitario Virgen de la Arrixaca, Murcia
Hospital Son Llàtzer, Palma de Mallorca
Hospital Universitari Son Espases, Palma de Mallorca
Hospital Sant Joan de Reus, Reus
Hospital Sagrado Corazón USP, Seville
Hospital Universitario Virgen del Rocío, Seville
Hospital Virgen de la Macarena, Seville
Fundación Instituto Valenciano de Oncología, Valencia
Hospital Arnau de Vilanova de Valencia, Valencia
Hospital Universitario Lozano Blesa, Zaragoza
SOLTI Breast Cancer Research Group
OTHER